pseudoephedrine

(redirected from Pseudoephedrine sulfate)
Also found in: Dictionary, Medical.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to pseudoephedrine

poisonous crystalline alkaloid occurring with ephedrine and isomorphic with it

Related Words

References in periodicals archive ?
5 mg and pseudoephedrine sulfate 120 mg) extended-release tablets for relief of nasal congestion and other symptoms of seasonal allergic rhinitis in patients aged 12 years and older.
of pseudoephedrine sulfate in a 24-hour extended release formulation.
Food and Drug Administration (FDA) has granted final approval to the Company's Abbreviated New Drug Application (ANDA) for a generic version of Claritin(R)-D 24-Hour (Loratadine and Pseudoephedrine Sulfate, 10mg/240mg) Extended Release Tablets.
The year-over-year increase for the fourth quarter was primarily due to shipments of over-the-counter (OTC) Loratadine and Pseudoephedrine Sulfate (5mg/120mg) 12-hour Extended Release Tablets and Flavoxate Hydrochloride 100mg Tablets (which began shipping during the fourth quarter of 2003), and higher sales of Fludrocortisone Tablets, Minocycline Capsules, and the LIPRAM product family.
Andrx Corporation (Nasdaq:ADRX) today announced that the United States Food and Drug Administration (FDA) has approved the Company's Abbreviated New Drug Application (ANDA) for Loratadine and Pseudoephedrine Sulfate Extended-release Tablets 5 mg/120 mg (12-Hour Formulation), which are bioequivalent to Schering Corporation's Claritin-D(R) 12 Hour Extended-release Tablets (Claritin-D12).
The significant year-over-year increases were primarily due to shipments of over-the-counter (OTC) Loratadine and Pseudoephedrine Sulfate (5mg/120mg) 12-hour Extended Release Tablets to Schering-Plough and to Wyeth during the third quarter of 2003; and higher sales of Fludrocortisone Tablets, Minocycline Capsules, and the LIPRAM product family.
NASDAQ:IPXL) today announced that it has entered into a settlement and license agreement with Schering-Plough Corporation (NYSE:SGP) related to IMPAX's generic version of Claritin-D(R) 24-Hour (Loratadine and Pseudoephedrine Sulfate, 10mg/240mg) Extended Release Tablets.
The Company continues to ship Loratadine and Pseudoephedrine Sulfate (5mg/120mg) 12-hour Extended Release Tablets to Schering-Plough and Wyeth under previously announced agreements for the over-the-counter market.